Regions Financial Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.7M | Buy |
34,745
+1,955
| +6% | +$1.33M | 0.13% | 124 |
|
|
2026
Q1 | $25.3M | Buy |
32,790
+29,914
| +1,040% | +$22.9M | 0.16% | 113 |
|
|
2025
Q4 | $2.22M | Buy |
2,876
+23
| +0.8% | +$15.6K | 0.01% | 363 |
|
|
2025
Q3 | $1.6M | Sell |
2,853
-25
| -0.9% | -$14.1K | 0.01% | 414 |
|
|
2025
Q2 | $1.51M | Buy |
2,878
+659
| +30% | +$368K | 0.01% | 421 |
|
|
2025
Q1 | $1.41M | Buy |
2,219
+1,376
| +163% | +$946K | 0.01% | 417 |
|
|
2024
Q4 | $600K | Sell |
843
-105
| -11% | -$88.1K | ﹤0.01% | 557 |
|
|
2024
Q3 | $997K | Buy |
948
+16
| +2% | +$17.8K | 0.01% | 491 |
|
|
2024
Q2 | $980K | Sell |
932
-232
| -20% | -$225K | 0.01% | 475 |
|
|
2024
Q1 | $1.12M | Buy |
1,164
+269
| +30% | +$256K | 0.01% | 474 |
|
|
2023
Q4 | $786K | Sell |
895
-23
| -3% | -$18.9K | 0.01% | 517 |
|
|
2023
Q3 | $755K | Sell |
918
-22
| -2% | -$17.3K | 0.01% | 502 |
|
|
2023
Q2 | $675K | Buy |
940
+42
| +5% | +$32.4K | 0.01% | 536 |
|
|
2023
Q1 | $737K | Buy |
898
+6
| +0.7% | +$4.53K | 0.01% | 536 |
|
|
2022
Q4 | $644K | Sell |
892
-35
| -4% | -$25.8K | 0.01% | 551 |
|
|
2022
Q3 | $639K | Sell |
927
-15
| -2% | -$9.44K | 0.01% | 538 |
|
|
2022
Q2 | $557K | Sell |
942
-119
| -11% | -$77.4K | 0.01% | 573 |
|
|
2022
Q1 | $741K | Sell |
1,061
-110
| -9% | -$69.6K | 0.01% | 556 |
|
|
2021
Q4 | $739K | Sell |
1,171
-5
| -0.4% | -$3.07K | 0.01% | 558 |
|
|
2021
Q3 | $711K | Sell |
1,176
-36
| -3% | -$22.3K | 0.01% | 555 |
|
|
2021
Q2 | $677K | Sell |
1,212
-252
| -17% | -$128K | 0.01% | 548 |
|
|
2021
Q1 | $693K | Sell |
1,464
-12
| -0.8% | -$5.84K | 0.01% | 523 |
|
|
2020
Q4 | $713K | Buy |
1,476
+160
| +12% | +$86.4K | 0.01% | 507 |
|
|
2020
Q3 | $736K | Buy |
1,316
+173
| +15% | +$105K | 0.01% | 465 |
|
|
2020
Q2 | $713K | Buy |
1,143
+3
| +0.3% | +$1.7K | 0.01% | 474 |
|
|
2020
Q1 | $556K | Sell |
1,140
-30
| -3% | -$12.4K | 0.01% | 484 |
|
|
2019
Q4 | $439K | Sell |
1,170
-71
| -6% | -$23.9K | ﹤0.01% | 564 |
|
|
2019
Q3 | $344K | Sell |
1,241
-117
| -9% | -$34.6K | ﹤0.01% | 605 |
|
|
2019
Q2 | $425K | Sell |
1,358
-15
| -1% | -$4.99K | ﹤0.01% | 561 |
|
|
2019
Q1 | $564K | Sell |
1,373
-156
| -10% | -$64.2K | 0.01% | 515 |
|
|
2018
Q4 | $571K | Sell |
1,529
-120
| -7% | -$43.9K | 0.01% | 493 |
|
|
2018
Q3 | $666K | Buy |
1,649
+86
| +6% | +$32.7K | 0.01% | 494 |
|
|
2018
Q2 | $539K | Sell |
1,563
-25
| -2% | -$7.82K | 0.01% | 534 |
|
|
2018
Q1 | $546K | Sell |
1,588
-96
| -6% | -$33.4K | 0.01% | 537 |
|
|
2017
Q4 | $633K | Buy |
1,684
+16
| +1% | +$6.48K | 0.01% | 514 |
|
|
2017
Q3 | $745K | Sell |
1,668
-83
| -5% | -$39.5K | 0.01% | 512 |
|
|
2017
Q2 | $860K | Sell |
1,751
-2
| -0.1% | -$875 | 0.01% | 475 |
|
|
2017
Q1 | $680K | Sell |
1,753
-4,316
| -71% | -$1.6M | 0.01% | 591 |
|
|
2016
Q4 | $2.23M | Sell |
6,069
-251
| -4% | -$95.4K | 0.03% | 264 |
|
|
2016
Q3 | $2.54M | Sell |
6,320
-39
| -0.6% | -$15.6K | 0.03% | 233 |
|
|
2016
Q2 | $2.22M | Buy |
6,359
+1,509
| +31% | +$581K | 0.03% | 263 |
|
|
2016
Q1 | $1.75M | Sell |
4,850
-1
| -0% | -$412 | 0.02% | 333 |
|
|
2015
Q4 | $2.63M | Sell |
4,851
-195
| -4% | -$106K | 0.04% | 235 |
|
|
2015
Q3 | $2.35M | Sell |
5,046
-86
| -2% | -$46.2K | 0.03% | 266 |
|
|
2015
Q2 | $2.62M | Sell |
5,132
-187
| -4% | -$91.3K | 0.03% | 256 |
|
|
2015
Q1 | $2.4M | Sell |
5,319
-287
| -5% | -$122K | 0.03% | 272 |
|
|
2014
Q4 | $2.3M | Sell |
5,606
-11,663
| -68% | -$4.59M | 0.03% | 281 |
|
|
2014
Q3 | $6.23M | Sell |
17,269
-1,005
| -5% | -$337K | 0.08% | 172 |
|
|
2014
Q2 | $5.16M | Buy |
18,274
+1,654
| +10% | +$490K | 0.06% | 191 |
|
|
2014
Q1 | $4.99M | Sell |
16,620
-659
| -4% | -$203K | 0.06% | 183 |
|
|
2013
Q4 | $4.76M | Sell |
17,279
-1,937
| -10% | -$557K | 0.06% | 189 |
|
|
2013
Q3 | $6.01M | Buy |
19,216
+2,830
| +17% | +$744K | 0.08% | 168 |
|
|
2013
Q2 | $3.69M | Buy |
+16,386
| New | +$3.82M | 0.05% | 202 |
|
Other funds holding REGN
Regions Financial Corp's REGN Position: Q2 2026 in Review
Regions Financial Corp increased its Regeneron Pharmaceuticals (REGN) stake by 6% in Q2 2026, buying an estimated $1.33M and bringing the position to 34,745 shares worth $21.7M. The position accounts for 0.13% of the portfolio, ranked #124.
Regions Financial Corp first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.3M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Regions Financial Corp held 34,745 shares of Regeneron Pharmaceuticals worth $21.7M as of Q2 2026.
- Regions Financial Corp bought 1,955 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.33M.
- Regeneron Pharmaceuticals made up 0.13% of Regions Financial Corp's portfolio in Q2 2026, its #124 holding.
- Regions Financial Corp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Regions Financial Corp's Regeneron Pharmaceuticals position peaked at $25.3M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.